The Now Corporation (OTC: NWPN) Acquires an Equity Stake In Enhanced Premium Water Brand, CellDration™
Ryan Allway February 23rd, 2022 Oakland Park, FL, Feb. 23, 2022 (GLOBE NEWSWIRE) — The Now Corporation (OTC Pink: NWPN), a bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC), is pleased to announce that in an effort to... Read more
Isracann Signs LOI to Acquire Natural Health Medicine Developer
Ryan Allway February 23rd, 2022 News, Top News VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) a biosciences company focused on researching and developing innovative health solutions in conjunction with its advanced stage activities aimed... Read more
Revitalist Executes on Mission to Build a National Network of Ketamine Clinics
Ryan Allway January 28th, 2022 Psychedelics, Top Story Psychedelics have shown tremendous promise in treating depression, anxiety, post-traumatic stress disorder, and a range of other mental health conditions. In particular, assisted psychotherapy combines psychedelic substances with talk therapy to facilitate breakthroughs and help patients that don’t see relief through... Read more
RYAH Closes Initial Tranche of Private Placement Units
Ryan Allway January 27th, 2022 News, Top News TORONTO, ON / ACCESSWIRE / January 27, 2022 / RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company“) is pleased to provide an update to its previously announced non-brokered private placement of units of the Company (“Units“) for aggregate gross proceeds of up... Read more
Revitalist Increases Clinic Count to Nine With Closing of Florida Clinic Acquisition
Ryan Allway January 12th, 2022 Psychedelics, Top News REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has executed an asset purchase agreement (“Agreement”) dated January 11, 2022, to acquire a Ketamine clinic located in Jacksonville, Florida... Read more
How to Capitalize on Europe’s Exploding CBD Market
Ryan Allway December 28th, 2021 App, Exclusive, News, Top Story Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing... Read more
Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way
Ryan Allway December 3rd, 2021 App, Exclusive, News, Top Story Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many... Read more
Ryan Allway November 18th, 2021 News, Top News CALGARY, AB, Nov. 18, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce its third quarter financial results for the three month period ending September 30, 2021. “Decibel’s continued growth is a... Read more
WestCann: A Unique Business Model with Plenty of Catalysts Ahead
Ryan Allway November 11th, 2021 News, Top Story The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and... Read more
Silo Pharma’s Sponsored Research Agreement with Columbia Could Yield a New Alzheimer’s Disease Treatment
Ryan Allway November 3rd, 2021 Psychedelics, Top Story Alzheimer’s disease is the sixth leading cause of death in the U.S. and a leading cause of disability and poor health. By 2050, iHealthcareAnalyst projects the number of people suffering from AD will reach 14 million in the U.S. alone. Yet,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )